Published in Tidsskr Nor Laegeforen on September 04, 2012
Anti-cytokine autoantibodies in autoimmune diseases. Am J Clin Exp Immunol (2012) 0.79
Rheumatoid arthritis increases the risk of nontuberculosis mycobacterial disease and active pulmonary tuberculosis. PLoS One (2014) 0.79
[Rituximab and neutropenia]. Tidsskr Nor Laegeforen (2012) 0.75
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol (2006) 2.96
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation (2007) 2.00
Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome. Arthritis Rheumatol (2014) 1.97
A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine (2009) 1.80
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet (2013) 1.79
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J (2009) 1.71
Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP. AIDS (2004) 1.54
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol (2006) 1.47
Should patients who use illicit drugs be offered a second heart-valve replacement? Tidsskr Nor Laegeforen (2013) 1.46
[Should patients with severe sepsis be treated with activated protein C?]. Tidsskr Nor Laegeforen (2004) 1.39
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation (2005) 1.38
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine (2010) 1.32
Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation (2002) 1.32
Systemic inflammation in heart failure--the whys and wherefores. Heart Fail Rev (2006) 1.30
Role of inflammation in the progression of heart failure. Curr Cardiol Rep (2007) 1.30
No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine (2010) 1.26
Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I. J Immunol (2003) 1.25
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol (2006) 1.21
Biological mechanisms of chronic fatigue. Rheumatology (Oxford) (2011) 1.20
Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial. Vaccine (2011) 1.18
Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets. J Immunol (2006) 1.14
T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. J Infect Dis (2012) 1.14
NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Sci Transl Med (2013) 1.12
Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis (2004) 1.11
Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res (2003) 1.10
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors. Circulation (2004) 1.07
Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation (2004) 1.07
A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol (2008) 1.06
Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS. Qual Life Res (2005) 1.05
Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease. J Am Coll Cardiol (2003) 1.04
Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol (2008) 1.02
Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res (2004) 1.00
Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial. PLoS One (2012) 1.00
Abnormal interleukin-7 function in common variable immunodeficiency. Blood (2004) 0.99
Whole genome gene expression meta-analysis of inflammatory bowel disease colon mucosa demonstrates lack of major differences between Crohn's disease and ulcerative colitis. PLoS One (2013) 0.98
Tickborne encephalitis virus, Norway and Denmark. Emerg Infect Dis (2006) 0.98
Fatigue in primary Sjögren's syndrome--a link to sickness behaviour in animals? Brain Behav Immun (2009) 0.97
Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells. Circulation (2004) 0.97
Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets. Circulation (2003) 0.97
Systemic lupus erythematosus, the brain, and anti-NR2 antibodies. J Neurol (2011) 0.97
Improved detection of advanced oxidation protein products in plasma. Clin Chim Acta (2012) 0.96
Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation. Clin Immunol (2008) 0.95
Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA. J Immunol Methods (2002) 0.95
Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats. Scand J Gastroenterol (2011) 0.95
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol (2005) 0.94
Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants. J Infect Dis (2003) 0.94
IL-10 enhances MD-2 and CD14 expression in monocytes and the proteins are increased and correlated in HIV-infected patients. J Immunol (2009) 0.93
Peripheral neuropathy in primary sjogren syndrome: a population-based study. Arch Neurol (2006) 0.93
A complex role of activin A in non-alcoholic fatty liver disease. Am J Gastroenterol (2009) 0.92
Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res (2002) 0.91
Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients. Blood (2005) 0.91
Soluble toll-like receptor 2 in HIV infection: association with disease progression. AIDS (2004) 0.91
Association between genetic variants in the tumour necrosis factor/lymphotoxin α/lymphotoxin β locus and primary Sjogren's syndrome in Scandinavian samples. Ann Rheum Dis (2012) 0.90
Primary Sjögren's syndrome associated neuropathy. Can J Neurol Sci (2007) 0.89
Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy. J Am Coll Cardiol (2003) 0.89
Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin. Autoimmun Rev (2004) 0.89
Churg-Strauss syndrome successfully treated with rituximab. Rheumatol Int (2009) 0.89
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment. AIDS (2006) 0.88
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever. J Infect (2008) 0.88
8-isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases. Cardiovasc Res (2003) 0.88
Potential anti-inflammatory role of activin A in acute coronary syndromes. J Am Coll Cardiol (2004) 0.88
Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 0.88
Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation. Rheumatology (Oxford) (2007) 0.87
Molecular characterization of Corynebacterium diphtheriae isolates, Russia, 1957-1987. Emerg Infect Dis (2002) 0.87
High resolution computed tomography and pulmonary function in common variable immunodeficiency. Respir Med (2009) 0.87
Genetic associations to germinal centre formation in primary Sjogren's syndrome. Ann Rheum Dis (2013) 0.86
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES. Arterioscler Thromb Vasc Biol (2005) 0.86
Enhanced plasma levels of LIGHT in unstable angina: possible pathogenic role in foam cell formation and thrombosis. Circulation (2005) 0.85
Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor alpha-dependent and -independent pathways. Arterioscler Thromb Vasc Biol (2005) 0.85
Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis. Infect Immun (2009) 0.85
Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome. Scand J Immunol (2013) 0.85
Patients with pulmonary hypertension related to congenital systemic-to-pulmonary shunts are characterized by inflammation involving endothelial cell activation and platelet-mediated inflammation. Congenit Heart Dis (2009) 0.85
Memory dysfunction in primary Sjögren's syndrome is associated with anti-NR2 antibodies. Arthritis Rheum (2013) 0.84
Expression of genes in normal human monocytes in response to Aspergillus fumigatus. Med Mycol (2008) 0.84
Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study. Circulation (2005) 0.84
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction. J Card Fail (2006) 0.84
Primary Sjögren's syndrome: fatigue is an ever-present, fluctuating, and uncontrollable lack of energy. Arthritis Care Res (Hoboken) (2014) 0.84
Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study. Arthritis Care Res (Hoboken) (2013) 0.83
Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis. Circ Res (2008) 0.83
Elevated levels of activin A in clinical and experimental pulmonary hypertension. J Appl Physiol (1985) (2009) 0.83
Coping, quality of life, and hope in adults with primary antibody deficiencies. Health Qual Life Outcomes (2005) 0.83
Potential association of muscarinic receptor 3 gene variants with primary Sjogren's syndrome. Ann Rheum Dis (2011) 0.83
Soluble CD40 ligand in acute and chronic heart failure. Eur Heart J (2005) 0.83
Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Arch Neurol (2006) 0.82
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation. J Am Coll Cardiol (2006) 0.82
Small-diameter nerve fiber neuropathy in systemic lupus erythematosus. Arch Neurol (2006) 0.82
Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. Ann Allergy Asthma Immunol (2010) 0.82
Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure. Eur J Heart Fail (2008) 0.82